Quantitative study examining the display of harmful and potentially harmful constituent information by product category
Ended Awarded Last action
- Contract number
- 75F40123F19029
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $43,598
Award facts
- Contract value 100% obligated
- $43,598.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$36,106 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $79,704 |
About this award
The Food and Drug Administration awarded a $43,598.05 firm fixed price Blanket Purchase Agreement call to Research Triangle Institute (RTI International), a non-profit research organization headquartered in Research Triangle Park, North Carolina. The contract, finalized on February 13, 2023, with a completion date of February 12, 2024, supports a quantitative study examining the display of harmful and potentially harmful constituent information by product category. This work aligns with the FDA's regulatory mission to protect public health through evidence-based policy and informed consumer disclosure standards. The award was made without a set-aside designation, reflecting RTI International's competitive capabilities as a premier research institution.
As a single non-profit contractor, RTI International brings substantial expertise in public health research, data analysis, and technical support to federal agencies. The organization's extensive experience with the FDA and other agencies such as the Centers for Disease Control and Prevention and National Institutes of Health positions it well to deliver rigorous quantitative analysis on product labeling and constituent disclosure practices. This engagement under the General Services Administration's Multiple Award Schedule demonstrates the efficiency of leveraging existing indefinite delivery vehicles for specialized research services that support critical FDA regulatory functions and consumer protection initiatives.
Quick answers
Who was awarded contract 75F40123F19029?
75F40123F19029 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on February 13, 2023.
How much is contract 75F40123F19029 worth?
The government has obligated $43,598 on 75F40123F19029.
Is contract 75F40123F19029 an order under another contract?
Yes. 75F40123F19029 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19029 competed?
The extent of competition for 75F40123F19029 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award